Vioxx Plaintiffs Take $5B Deal Woes To High Court
By Melissa Lipman ( November 18, 2010, 7:06 PM EST) -- A group of plaintiffs challenging Merck & Co. Inc.'s $4.85 billion settlement of multidistrict litigation over its painkiller Vioxx has asked the U.S. Supreme Court to consider whether the mass settlement ran afoul of federal procedure by setting up a "quasi-class action" that allegedly stripped some plaintiffs of their rights....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.